The Filing Desk

Spectral AI vs Nephros

Spectral AI MDAI · Nephros NEPH · Health Care Equipment

Spectral AI reported revenue of $20 million in fiscal 2025, about the same as Nephros' $19 million in fiscal 2025. Spectral AI's revenue fell 33.6% in its latest year, and Nephros' grew 32.7%. Spectral AI had an operating margin of -43.8%, against 6.1% at Nephros.

Side by side

Spectral AINephros
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$20M$19M
Revenue growth−33.6%32.7%
Revenue growth a year, last 5 years—16.9%
Gross margin45.4%61.9%
Operating margin−43.8%6.1%
Net margin−38.5%6.3%
Free cash flow——
Free cash flow margin——
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count47.9%3.5%
Last close$1.31$2.84
P/E at the last close—15.8×
Insider trades, last 12 months—bought $22,075, sold $0
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Spectral AINephros
Operating margin
Percent of revenue
Spectral AINephros
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Spectral AINephros

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Spectral AI and Nephros pages.